Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Intravenous Immunoglobulin
1.2.3 Plasma Exchange
1.2.4 Others
1.3 Market by Application
1.3.1 Global Guillain-Barré Syndrome Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Guillain-Barré Syndrome Market Perspective (2018-2033)
2.2 Guillain-Barré Syndrome Growth Trends by Region
2.2.1 Global Guillain-Barré Syndrome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Guillain-Barré Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Guillain-Barré Syndrome Forecasted Market Size by Region (2024-2033)
2.3 Guillain-Barré Syndrome Market Dynamics
2.3.1 Guillain-Barré Syndrome Industry Trends
2.3.2 Guillain-Barré Syndrome Market Drivers
2.3.3 Guillain-Barré Syndrome Market Challenges
2.3.4 Guillain-Barré Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barré Syndrome Players by Revenue
3.1.1 Global Top Guillain-Barré Syndrome Players by Revenue (2018-2023)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Guillain-Barré Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barré Syndrome Revenue
3.4 Global Guillain-Barré Syndrome Market Concentration Ratio
3.4.1 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barré Syndrome Revenue in 2022
3.5 Guillain-Barré Syndrome Key Players Head office and Area Served
3.6 Key Players Guillain-Barré Syndrome Product Solution and Service
3.7 Date of Enter into Guillain-Barré Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guillain-Barré Syndrome Breakdown Data by Type
4.1 Global Guillain-Barré Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Guillain-Barré Syndrome Forecasted Market Size by Type (2024-2033)
5 Guillain-Barré Syndrome Breakdown Data by Application
5.1 Global Guillain-Barré Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Guillain-Barré Syndrome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Guillain-Barré Syndrome Market Size (2018-2033)
6.2 North America Guillain-Barré Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Guillain-Barré Syndrome Market Size by Country (2018-2023)
6.4 North America Guillain-Barré Syndrome Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Guillain-Barré Syndrome Market Size (2018-2033)
7.2 Europe Guillain-Barré Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Guillain-Barré Syndrome Market Size by Country (2018-2023)
7.4 Europe Guillain-Barré Syndrome Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barré Syndrome Market Size (2018-2033)
8.2 Asia-Pacific Guillain-Barré Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Guillain-Barré Syndrome Market Size (2018-2033)
9.2 Latin America Guillain-Barré Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Guillain-Barré Syndrome Market Size by Country (2018-2023)
9.4 Latin America Guillain-Barré Syndrome Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barré Syndrome Market Size (2018-2033)
10.2 Middle East & Africa Guillain-Barré Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Guillain-Barré Syndrome Introduction
11.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.1.5 Grifols Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Detail
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Guillain-Barré Syndrome Introduction
11.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.2.5 CSL Behring Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Detail
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Guillain-Barré Syndrome Introduction
11.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.3.5 Octapharma Recent Development
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Detail
11.4.2 Nihon Pharmaceutical Business Overview
11.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Introduction
11.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.4.5 Nihon Pharmaceutical Recent Development
11.5 Akari Therapeutics
11.5.1 Akari Therapeutics Company Detail
11.5.2 Akari Therapeutics Business Overview
11.5.3 Akari Therapeutics Guillain-Barré Syndrome Introduction
11.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.5.5 Akari Therapeutics Recent Development
11.6 China Biologic Products Holdings
11.6.1 China Biologic Products Holdings Company Detail
11.6.2 China Biologic Products Holdings Business Overview
11.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Introduction
11.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.6.5 China Biologic Products Holdings Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Guillain-Barré Syndrome Introduction
11.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.7.5 Biotest Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Detail
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Guillain-Barré Syndrome Introduction
11.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2018-2023)
11.8.5 Kedrion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Guillain-Barré Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Intravenous Immunoglobulin
Table 3. Key Players of Plasma Exchange
Table 4. Key Players of Others
Table 5. Global Guillain-Barré Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Guillain-Barré Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Guillain-Barré Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Guillain-Barré Syndrome Market Share by Region (2018-2023)
Table 9. Global Guillain-Barré Syndrome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Guillain-Barré Syndrome Market Share by Region (2024-2033)
Table 11. Guillain-Barré Syndrome Market Trends
Table 12. Guillain-Barré Syndrome Market Drivers
Table 13. Guillain-Barré Syndrome Market Challenges
Table 14. Guillain-Barré Syndrome Market Restraints
Table 15. Global Guillain-Barré Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Guillain-Barré Syndrome Market Share by Players (2018-2023)
Table 17. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barré Syndrome as of 2022)
Table 18. Ranking of Global Top Guillain-Barré Syndrome Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Guillain-Barré Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Guillain-Barré Syndrome Product Solution and Service
Table 22. Date of Enter into Guillain-Barré Syndrome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Guillain-Barré Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Guillain-Barré Syndrome Revenue Market Share by Type (2018-2023)
Table 26. Global Guillain-Barré Syndrome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Guillain-Barré Syndrome Revenue Market Share by Type (2024-2033)
Table 28. Global Guillain-Barré Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Guillain-Barré Syndrome Revenue Market Share by Application (2018-2023)
Table 30. Global Guillain-Barré Syndrome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Guillain-Barré Syndrome Revenue Market Share by Application (2024-2033)
Table 32. North America Guillain-Barré Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Guillain-Barré Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Guillain-Barré Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Guillain-Barré Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Guillain-Barré Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Guillain-Barré Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Guillain-Barré Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Guillain-Barré Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Guillain-Barré Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Guillain-Barré Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Guillain-Barré Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 47. Grifols Company Detail
Table 48. Grifols Business Overview
Table 49. Grifols Guillain-Barré Syndrome Product
Table 50. Grifols Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 51. Grifols Recent Development
Table 52. CSL Behring Company Detail
Table 53. CSL Behring Business Overview
Table 54. CSL Behring Guillain-Barré Syndrome Product
Table 55. CSL Behring Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 56. CSL Behring Recent Development
Table 57. Octapharma Company Detail
Table 58. Octapharma Business Overview
Table 59. Octapharma Guillain-Barré Syndrome Product
Table 60. Octapharma Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 61. Octapharma Recent Development
Table 62. Nihon Pharmaceutical Company Detail
Table 63. Nihon Pharmaceutical Business Overview
Table 64. Nihon Pharmaceutical Guillain-Barré Syndrome Product
Table 65. Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 66. Nihon Pharmaceutical Recent Development
Table 67. Akari Therapeutics Company Detail
Table 68. Akari Therapeutics Business Overview
Table 69. Akari Therapeutics Guillain-Barré Syndrome Product
Table 70. Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 71. Akari Therapeutics Recent Development
Table 72. China Biologic Products Holdings Company Detail
Table 73. China Biologic Products Holdings Business Overview
Table 74. China Biologic Products Holdings Guillain-Barré Syndrome Product
Table 75. China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 76. China Biologic Products Holdings Recent Development
Table 77. Biotest Company Detail
Table 78. Biotest Business Overview
Table 79. Biotest Guillain-Barré Syndrome Product
Table 80. Biotest Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 81. Biotest Recent Development
Table 82. Kedrion Company Detail
Table 83. Kedrion Business Overview
Table 84. Kedrion Guillain-Barré Syndrome Product
Table 85. Kedrion Revenue in Guillain-Barré Syndrome Business (2018-2023) & (US$ Million)
Table 86. Kedrion Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barré Syndrome Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Guillain-Barré Syndrome Market Share by Type: 2022 VS 2033
Figure 3. Intravenous Immunoglobulin Features
Figure 4. Plasma Exchange Features
Figure 5. Others Features
Figure 6. Global Guillain-Barré Syndrome Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Guillain-Barré Syndrome Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Guillain-Barré Syndrome Report Years Considered
Figure 12. Global Guillain-Barré Syndrome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Guillain-Barré Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Guillain-Barré Syndrome Market Share by Region: 2022 VS 2033
Figure 15. Global Guillain-Barré Syndrome Market Share by Players in 2022
Figure 16. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barré Syndrome as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Guillain-Barré Syndrome Revenue in 2022
Figure 18. North America Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Guillain-Barré Syndrome Market Share by Country (2018-2033)
Figure 20. United States Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Guillain-Barré Syndrome Market Share by Country (2018-2033)
Figure 24. Germany Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Guillain-Barré Syndrome Market Share by Region (2018-2033)
Figure 32. China Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Guillain-Barré Syndrome Market Share by Country (2018-2033)
Figure 40. Mexico Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Guillain-Barré Syndrome Market Share by Country (2018-2033)
Figure 44. Turkey Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Guillain-Barré Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Grifols Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 47. CSL Behring Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 48. Octapharma Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 49. Nihon Pharmaceutical Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 50. Akari Therapeutics Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 51. China Biologic Products Holdings Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 52. Biotest Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 53. Kedrion Revenue Growth Rate in Guillain-Barré Syndrome Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed